Researchers are developing a new, first-in-class agent that has stopped the growth of estrogen receptor-positive breast cancer in its tracks.
Read More ›
Zebrafish may hold the key to understanding how children who have a rare muscle cancer relapse and don’t respond to treatment.
A potential cure for Type 1 diabetes is on the horizon, and the novel approach would also allow Type 2 diabetics to stop insulin shots.
Talk therapy can lead to recovery from post-traumatic stress disorder for those who suffer from combat-related PTSD.
Rates of liver cancer continue to be high for Latinos. Contaminated food may be to blame.
Over four decades, the Mass Spectrometry Laboratory has been a part of countless research projects—in a range of disciplines—conducted at the university.
Two weeks is all it took for deadly, late-stage head and neck tumors to shrink in mouse models. The cause: a combination of two targeted treatments already approved by the FDA.
What if there were a safe and effective way to control pain at its source, tailored to each patient, yet without the risk of addiction and overdose?
Philanthropists Joe R. and Teresa Lozano Long have supported scholarships since 1999. But their impact goes beyond dollars.
In ancient times, medical advances were made through a mixture of trial and error. Today’s trials are a far cry from the methods of discovery made by early civilizations.